BNTC
Benitec Biopharma Ltd
9.60$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.4% | +12.5% | +1.1% | +0.0% | -11.0% | +30.9% | +11.3% | +0.0% | +1.7% | -0.8% | +4.2% | – | |
| – | +2.2% | +106.5% | +136.5% | -4.2% | +116.8% | +175.4% | +417.9% | -61.5% | +42.5% | +2.9% | -17.6% | – | |
| – | +3.9% | -272.8% | – | -106.0% | – | – | -935.0% | – | -172.9% | – | – | – | |
| – | – | +6,273,466.4% | -99.7% | -100.0% | – | -50.0% | -92.2% | -100.0% | – | +45.8% | +392.5% | – | |
| – | – | – | -99.7% | – | – | -50.0% | -92.2% | – | – | +45.8% | +392.5% | – | |
| – | -100.2% | – | +25,771.5% | -46.0% | -17.5% | +59.0% | -84.9% | -100.0% | – | -95.6% | -94.5% | – | |
| – | -123.5% | – | – | -53.8% | -38.5% | +142.3% | -122.9% | – | – | -104.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.